SEARCH

SEARCH BY CITATION

Additional supporting information may be found in the online version of this article at the publisher's web-site.

FilenameFormatSizeDescription
jcb24711-sm-0001-SuppFig-S1.tif3244KFig. S1. Tandem mass spectrogram of the components obtained from the separation after SDS–PAGE process.
jcb24711-sm-0002-SuppFig-S2.tif63078KFig. S2. Graphic quantification of flow cytometric analysis. A: Percentage variation of the CD44 (+) and CD44 (−) fractions in MKN45 cells treated with different doses of ACBP-3. B: The cell status in MKN45 CD44 (−) fraction treated with different doses of ACBP-3. C: The cell status in MKN45 CD44 (+) fraction treated with different doses of ACBP-3. D: Percentage variation of the CD44 (+) and CD44 (−) fractions in MKN74 cells treated with different doses of ACBP-3. E: The cell status in MKN74 CD44 (−) fraction treated with different doses of ACBP-3. F: The cell status in MKN74 CD44 (+) fraction treated with different doses of ACBP-3. *P < 0.05 compared to the control. #P < 0.05 compared to 13 μg/ml ACBP-3 group. P < 0.05 compared to 19 μg/ml ACBP-3 group.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.